ICCC Projected Dividend Yield
ImmuCell Corp. ( NASDAQ : ICCC )ImmuCell Corporation is an animal health company. Co. is engaged in the development, acquisition, manufacture, and sale of products that improve the health and productivity of dairy and beef cattle. It operates in two business segments: Scours and Mastitis. The Scours segment is engaged in manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the U.S. Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows. 20 YEAR PERFORMANCE RESULTS |
ICCC Dividend History Detail ICCC Dividend News ICCC Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |